A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients...
BUENOS AIRES, Argentina — In a significant legal development, a U.S. judge has mandated that Argentina relinquish its 51% controlling stake in the state-run...